Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "UAE Genetic Testing Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
UAE Genetic Testing Market was valued at USD 32.46 million in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 20.32% through 2029
Advances in prenatal screening and diagnostic technologies contribute to the growth of genetic testing services for expectant parents. Direct-to-consumer genetic testing services that offer insights into ancestry and heritage have gained popularity. Consumer interest in understanding genetic origins contributes to the overall growth of the genetic testing market. Integration of genetic testing into routine healthcare practices and guidelines can drive adoption. As healthcare professionals become more familiar with the clinical utility of genetic information, testing becomes a standard part of patient care.
The Abu Dhabi region dominated the UAE Genetic Testing Market in 2023. Abu Dhabi is known for its advanced healthcare infrastructure, including state-of-the-art medical facilities and research institutions. A well-developed healthcare ecosystem is crucial for the growth of genetic testing services. Abu Dhabi serves as a hub for research and innovation in the healthcare sector, it is likely to attract genetic testing companies and research initiatives. Proximity to leading research institutions can foster collaborations and advancements in the field. The government of Abu Dhabi has specific initiatives or policies supporting the development of genetic testing services, it can create a favorable environment for the industry to thrive.
The dominance of Abu Dhabi in the genetic testing market could be influenced by strategic partnerships between local healthcare providers, research institutions, and international biotech companies specializing in genetic testing. Abu Dhabi might have a higher population density and diversity, making it a more attractive market for genetic testing services. A diverse population often presents a broader range of genetic variations and healthcare needs.
Increased Demand for Non-Invasive Prenatal Testing (NIPT)
NIPT offers high accuracy in detecting common chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), among others. Early detection during the first trimester provides expectant parents with more time to make informed decisions about their pregnancy. NIPT is a non-invasive procedure that only requires a blood sample from the pregnant woman. This reduces the risk compared to invasive procedures like amniocentesis or chorionic villus sampling (CVS). Increased awareness among pregnant women and healthcare providers about the availability and benefits of NIPT contributes to its rising demand.
Educational campaigns and information dissemination may play a role in promoting the adoption of NIPT. Advanced maternal age is associated with an increased risk of chromosomal abnormalities. As maternal age trends upward, there is a growing interest in early and accurate prenatal screening. There is increased insurance coverage or affordability of NIPT, it can drive demand by making the testing more accessible to a broader range of expectant parents. Many expectant parents may prefer non-invasive testing methods to avoid the potential risks associated with invasive procedures, even if they have lower associated risks.
Increasing Prenatal and Neonatal Testing
Prenatal testing allows for the early detection of genetic conditions in developing fetuses. Neonatal testing identifies genetic disorders in newborns shortly after birth. Prenatal genetic testing provides expectant parents with information about the health of their unborn child. This knowledge allows parents to make informed decisions about the pregnancy, including possible medical interventions or preparations for the care of a child with special needs. Genetic testing is often recommended in high-risk pregnancies, such as those with a family history of genetic disorders or maternal age-related risks. Early identification of genetic issues helps healthcare providers manage high-risk pregnancies more effectively.
Genetic testing during pregnancy can identify conditions for which preventive measures or early treatments are available. Neonatal testing allows for the prompt initiation of medical interventions that can significantly improve outcomes for affected newborns. Prenatal screening, such as non-invasive prenatal testing (NIPT), allows for the assessment of chromosomal abnormalities in the fetus.
Identifying conditions like Down syndrome during pregnancy enables parents to prepare for the potential needs of a child with such a condition. Genetic testing can determine if parents are carriers of specific genetic conditions that may affect their offspring. Knowledge of carrier status helps parents understand the risk of passing on genetic disorders and allows for family planning decisions. Information obtained through prenatal and neonatal testing influences family planning decisions. Couples may decide to undergo genetic testing during pregnancy to understand the likelihood of genetic conditions in their children.
Prenatal and neonatal testing provides parents with information about the health of their child, offering peace of mind or, if necessary, time to prepare for potential challenges. Technological advancements, such as next-generation sequencing, have enhanced the accuracy and scope of prenatal and neonatal genetic testing. These technological improvements contribute to the broader adoption of genetic testing in pregnancy.
Public health programs may recommend or mandate certain prenatal and neonatal genetic tests to screen for common genetic disorders. Awareness and education campaigns associated with public health initiatives promote the importance of genetic testing during pregnancy. Prenatal and neonatal genetic testing often involves genetic counseling services. Genetic counselors provide support and guidance to parents, helping them understand test results and make informed decisions. This factor will accelerate the demand of the UAE Genetic Testing Market.
UAE Genetic Testing Market Segment Highlights
Predictive & Presymptomatic Testing:
- Dominated the market in 2023 and is expected to continue expanding.
- Focuses on preventive healthcare, allowing individuals to assess the risk of developing conditions before symptoms appear.
- Supports the trend of personalized medicine, guiding tailored treatment and prevention plans.
- Often linked to assessing hereditary cancer risks, which drives demand in regions with high cancer awareness.
- Genetic counseling services enhance the appeal by helping individuals understand their risks.
Sickle Cell Anemia:
- Held the largest share of the market in 2023 and is anticipated to grow further.
- More prevalent in populations with origins from areas where the sickle cell gene is common.
- Public health initiatives in the UAE aimed at addressing genetic disorders may drive testing demand.
- Early detection and management of Sickle Cell Anemia underscore the importance of genetic testing services.
- Increased awareness and education programs about genetic disorders could lead to higher testing rates for Sickle Cell Anemia.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 75 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value (USD) in 2023 | $32.46 Million |
| Forecasted Market Value (USD) by 2029 | $97.65 Million |
| Compound Annual Growth Rate | 20.3% |
| Regions Covered | United Arab Emirates |
Report Scope:
Key Market Players in UAE's Genetic Testing Market
- Freiburg Medical Laboratory Middle East LLC
- Fakih IVF Center
- Beyond Nutrition Health and Wellness Services DMCC
- Genesis Healthcare Center
- Dante Labs
- Reem Medical Group
UAE Genetic Testing Market, By Type:
- Carrier Testing
- Diagnostic Testing
- New-born Screening
- Predictive & Presymptomatic Testing
- Prenatal Testing
- Others
UAE Genetic Testing Market, By Disease:
- Sickle Cell Anemia
- Thalassemia
- Huntington's Disease
- Cancer
- Others
UAE Genetic Testing Market, By Technology:
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
UAE Genetic Testing Market, By Service Providers:
- Clinical & Metabolic Specialists
- Genetic Counsellors
- Diagnostic Laboratories
- Hospitals
UAE Genetic Testing Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of UAE
For more information about this report visit https://www.researchandmarkets.com/r/ix47nh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
